Hypertension in women: Current understanding of gender differences

Mayo Clinic Proceedings

Volumn 73, Issue 2, 1998, Pages 157-165

  Hayes, Sharonne N ^a,b,c   Taler, Sandra J ^a,b  

^a Division of Cardiovascular Diseases and Internal Medicine   (United States)

^b Division of Nephrology   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

HEART LEFT VENTRICLE HYPERTROPHY; HORMONE SUBSTITUTION; HYPERTENSION; KIDNEY ARTERY STENOSIS; MEDICAL RESEARCH; ORAL CONTRACEPTION; REVIEW; SEX DIFFERENCE;

EID: 0031885332     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(11)63649-5     Document Type: Article

References (67)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Hypertension 1995:25:305-313
2. Black HR, Cohen JD, Kaplan NM, Ferdinand KC, Chobanian AV, Dustan HP, et al. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157-.2413-2445
3. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials. Ann Intern Med 1997;126:761-767
4. Kännel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J 1987; 114:413-419
5. Anastos K, Charney P, Charon RA, Cohen E, Jones CY, Marte C, et al. Hypertension in women: what is really known? Ann Intern Med 1991;115:287-293
6. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996:335:257-265
7. Woods JW. Oral contraceptives and hypertension. Hypertension 1988;ll(Suppl 2):II11-II15
8. Chasan-Taber L, Willett WC, Manson JE, Spiegelman D, Hunter DJ, Curhan G, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996;94:483489
9. Spellacy WN, Birk SA. The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure. Am J Obstet Gynecol 1972;112:912-919
10. Clezy TM, Foy BN, Hodge RL, Lumbers ER. Oral contraceptives and hypertension: an epidemiological survey. Br Heart J 1972:34:12381243
11. Fisch IR, Freedman SH, Myatts AV. Oral contraceptives, pregnancy, and blood pressure. JAMA 1972:222:1507-1510
12. Task Force on Oral Contraceptives. The WHO multicentre trial of the vasopressor effects of combined oral contraceptives. 1. Comparisons with IUD. Contraception 1989;40:129-145
13. Spellacy WN, Birk SA. The effects of mechanical and steroid contraceptive methods on blood pressure in hypertensive women. Fertil Steril 1974:25:467-470
14. Pritchard JA, Pritchard SA. Blood pressure response to estrogenprogestin oral contraceptive after pregnancy-induced hypertension. Am J Obstet Gynecol 1977;129:733-739
15. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995:273:199-208
16. Nordby G, Haaland A, Os I. Evidence of decreased fibrinolytic activity in hypertensive premenopausal women. Scand J Clin Lab Invest 1992:52:275-281
17. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39-45
18. Fisher ND, Ferri C, Bellini C, Santucci A, Gleason R, Williams GH, et al. Age, gender, and non-modulation: a sexual dimorphism in essential hypertension. Hypertension 1997:29:980-985
19. Messerli FH, Sundgaard-Riise K, Ventura HO, Dunn FG, Glade LB, Fröhlich ED. Essential hypertension in the elderly: hemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 1983:2:983-986
20. Messerli FH, Garavaglia GE, Schmieder RE, Sundgaard-Riise K, Nunez BD, Amodeo C. Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 1987;107:158161
21. Karpanou EA, Vyssoulis GP, Papakyriakou SA, Toutouza MG, Toutouzas PK. Effects of menopause on aortic root function in hypertensive women. J Am Coll Cardiol 1996;28:1562-1566
22. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839-842
23. Mercuro G, Zoncu S, Pilia I, Lao A, Melis GB, Cherchi A. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am J Cardiol 1997;80:652655
24. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol 1995:75:264-268
25. Rajkumar C, Kingwell BA, Cameron JD, Waddell T, Mehra R, Christophidis N, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997;30:350356
26. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990:322:15611566
27. Hinderliter AL, Light KC, Willis PW IV. Gender differences in left ventricular structure and function in young adults with normal or marginally elevated blood pressure. Am J Hypertens 1992;5:3236
28. Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994;90:928-936
29. Gardin JM, Wagenknecht LE, Anton-Culver H, Rack J, Gidding S, Kurosaki T, et al. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women: the CARDIA study. Circulation 1995:92:380-387
30. Garavaglia GE, Messerli FH, Schmieder RE, Nunez BD, Oren S. Sex differences in cardiac adaptation to essential hypertension. Eur Heart J 1989:10:1110-1114
31. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993:72:310-313
32. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994:23:600-606
33. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61
34. Liao Y, Cooper RS, Mensah GA, McGee DL. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995:92:805-810
35. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996:275:15571562
36. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Sacchi N, Battistelli M, et al. Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension: dippers and peakers. Am J Hypertens 1995:8:193-196
37. Acharya DU, Heber ME, Dore CJ, Raftery EB. Ambulatory intraarterial blood pressure in essential hypertension: effects of age, sex, race, and body mass-the Northwick Park Hospital Database Study. Am J Hypertens 1996:9:943-952
38. Broadhurst P, Brigden G, Dasgupta P, Lahiri A, Raftery EB. Ambulatory intra-arterial blood pressure in normal subjects. Am Heart J 1990:120:160-166
39. Verdecchia P, Schillaci G, Gatteschi C, Zampi I, Battistelli M, Bartoccini C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993:88:986-992
40. Diamond JA, Krakoff LR, Martin K, Wallenstein S, Phillips RA. Com parison of ambulatory blood pressure and amounts of left ventricular hypertrophy in men versus women with similar levels of hypertensive clinic blood pressures. Am J Cardiol 1997:79:505-508
41. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R, et al. White coat hypertension and white coat effect: similarities and differences. Am J Hypertens 1995:8:790-798
42. Kojima S, Murakami K, Kimura G, Sana! T, Yoshida K, Imanishi M, et al. A gender difference in the association between salt sensitivity and family history of hypertension. Am J Hypertens 1992;5:l-7
43. Lehrer S, Rabin J, Kalir T, Schachter BS. Estrogen receptor variant and hypertension in women. Hypertension 1993:21:439-441
44. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm/Hg. JAMA 1970;213:1143-1152
45. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982:248:1465-1477
46. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial; the Oslo Study. Am J Med 1980:69:725-732
47. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991:265:3255-3264
48. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985:1:13491354
49. Dahlof B, Hansson L, Lindholm LH, Schersten B, Ekbom T, Wester PO. Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) analyses performed up to 1992. Clin Exp Hypertens 1993:15:925-939
50. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits JA, Elmer PJ, et al (Treatment of Mild Hypertension Study Research Group). Treatment of Mild Hypertension Study: final results. JAMA 1993;270:713724
51. Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. JAMA 1979:242:2572-2577
52. The Australian therapeutic trial in mild hypertension: report by the management committee. Lancet 1980;1:1261-1267
53. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985:291:97-104
54. Hypertension Detection and Follow-Up Program Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-Up Program. JAMA 1988:259:2113-2122
55. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405412
56. Nunnelee JD. The inclusion of women in clinical trials of antihypertensive medications: a review of twenty-four trials in one pharmacology journal. J Vase Nurs 1995:13:41-49
57. Lewis CE, Grandits GA, Flack J, McDonald R, Elmer PJ. Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension: results of the Treatment of Mild Hypertension Study. Arch Intern Med 1996:156:377-385
58. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, et al (SHEP Cooperative Research Group). Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997:278:212-216
59. Applegate WB, Presse! S, Wittes J, Luhr J, Shekelle RB, Camel GH, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the systolic hypertension in the elderly program. Arch Intern Med 1994;154:2154-2160
60. Perry HM Jr, Hall WD, Benz JR, Bartels DW, Kastis JB, Townsend RR, et al. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women. Am J Med 1994:96:77-86
61. Applegate WB, Phillips HL, Schnaper H, Shepherd AM, Schocken D, Luhr JC, et al. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991:151:1817-1823
62. Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M (Amlodipine Cardiovascular Community Trial Study Group). Sex and age-related antihypertensive effects of amlodipine. Am J Cardiol 1996:77:713722
63. Abramow M, Cogan E. Clinical aspects and pathophysiology of diuretic-induced hyponatremia. Adv Nephrol Necker Hosp 1984:13:128
64. van Gilst WH, Tijssen JG, van Es GA, Lubsen J. Serum potassium values in relation to the use of diuretics in patients with unstable angina pectoris. Eur Heart J 1988:9:795-799
65. Gibson GR. Enalapril-induced cough. Arch Intern Med 1989:149:2701-2703
66. Os l, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994;7:1012-1015.
67. Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997:29:8-14